glp 1 and hot flashes GLP-1 Agonists in Perimenopause: Unique Risks Potential Opportunities GLP-1 & Menopause: Evidence-Based Support

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults

Cheaper generics promise wider access, yet specialists flag safety, storage and overuse concerns

The company attributes the turnaround to changed GLP-1 policies, a milder flu season and workforce buyouts that affected roughly 18% of employees.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, antioxidant, and neuroprotective propertiesthat position them as transformative candidates ...

If you plan to use a GLP-1 medication in 2025, consider increasing your FSA or HSA contributions

The GLP-1 Plate : The Science of Activating Endogenous GLP-1 Through Whole Food Chemistry, Bone Broth, and Strategic Fasting - Kindle edition by Zimmerman, Veronica D